Fundamentals

Valuation

Metric	Q4	Q1	Δ in %
EV/EBITDA	56.74	-635.03	-1468.11
Graham Fair Price	-4.97	13.82	14.54
PEG	404.45	8.76	1.74
Price/Book	12.25	2.62	2.33
Price/Cash Flow	-11.97	72.76	82.65
Prices/Earnings	-24.84	-97.32	-77.95
Price/Sales	11.28	25.24	22.68
Price/FCF	-11.97	72.76	82.65
Naive Interpretation	member

01 - Valuation · Bad

Fundamentals

Profitability

Metric	Q4	Q1	Δ in %
Gross Profit Margin	-0.03	0.76	0.76
Operating Margin	44.47	-0.08	-0.14
ROA	8.75	< 0.005	< 0.005
ROE	< 0.005	< 0.005	10.08
ROIC	-0.01	-0.01	-0.17
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q4	Q1	Δ in %
Debt QOQ	-0.03	-0.09	69.96
Dividends QOQ	0.00	0.00	0.00
EBIT QOQ	0.25	0.43	71.94
EPS QOQ	0.45	0.11	-75.25
FCF QOQ	0.11	0.29	153.44
Revenue QOQ	0.04	0.02	-44.84
Naive Interpretation	member

03 - Financial Growth · Weak

Fundamentals

Leverage & Liquidity

Metric	Q4	Q1	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	0.00	0.00	0.00
Days Sales Outstanding (DSO)	86.13	48.14	-44.11
Inventory Turnover	0.00	0.00	0.00
Debt/Capitalization	0.17	0.16	-3.01
Quick Ratio	1.56	1.57	0.68
Naive Interpretation	member

04 - Leverage & Liquidity · Weak

Fundamentals

Per Share Metrics

Metric	Q4	Q1	Δ in %
Book Value	35.47	35.55	0.22
Cash	13.28	13.86	4.39
Capex	-0.05	-0.03	38.05
Free Cash Flow	1.00	1.28	27.79
Revenue	3.64	3.68	1.09
Naive Interpretation	member

05 - Per Share Metrics · Best

Fundamentals

Financial Health

Metric	Q4	Q1	Δ in %
Current Ratio	1.61	1.66	3.22
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	-96.10	-36.15	62.38
Naive Interpretation	Member

06 - Financial Health · Weak

Rating